Cargando…

Type-specific prevalence of human papillomavirus in women screened for cervical cancer in Labrador, Canada

BACKGROUND: A higher incidence of cervical cancer and human papillomavirus (HPV) infection has been reported in northern Canada and in First Nation, Métis and Inuit women, with some evidence to suggest that the HPV type distribution in these populations may be different from the rest of Canada. OBJE...

Descripción completa

Detalles Bibliográficos
Autores principales: Severini, Alberto, Jiang, Ying, Brassard, Paul, Morrison, Howard, Demers, Alain A., Oguntuase, Elizabeth, Al-Rushdi, Muna, Preston, Felicia, Ratnam, Samuel, Mao, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579953/
https://www.ncbi.nlm.nih.gov/pubmed/23440347
http://dx.doi.org/10.3402/ijch.v72i0.19743
_version_ 1782260195405070336
author Severini, Alberto
Jiang, Ying
Brassard, Paul
Morrison, Howard
Demers, Alain A.
Oguntuase, Elizabeth
Al-Rushdi, Muna
Preston, Felicia
Ratnam, Samuel
Mao, Yang
author_facet Severini, Alberto
Jiang, Ying
Brassard, Paul
Morrison, Howard
Demers, Alain A.
Oguntuase, Elizabeth
Al-Rushdi, Muna
Preston, Felicia
Ratnam, Samuel
Mao, Yang
author_sort Severini, Alberto
collection PubMed
description BACKGROUND: A higher incidence of cervical cancer and human papillomavirus (HPV) infection has been reported in northern Canada and in First Nation, Métis and Inuit women, with some evidence to suggest that the HPV type distribution in these populations may be different from the rest of Canada. OBJECTIVE: The objective of this study was to measure the HPV type prevalence in Labrador women to determine if significant differences in HPV types could reduce the effectiveness of HPV vaccination. DESIGN: The prevalence of HPV types was determined in 1,370 women presenting for routine pap screening in Labrador between February and November 2010. Cervical cytology and HPV genotyping were performed on the same liquid-based cytology specimens. RESULTS: The overall prevalence of HPV was 21.4%; cytological abnormalities were found in 8.8% of the participants. HPV 16 and 18 were the most common high-risk HPV types. These two types were found in 52.4% of high-grade lesions. The prevalence in HPV infections was comparable across the Labrador regions. CONCLUSIONS: The present results support the potential effectiveness of the HPV immunization program in Labrador.
format Online
Article
Text
id pubmed-3579953
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Co-Action Publishing
record_format MEDLINE/PubMed
spelling pubmed-35799532013-02-25 Type-specific prevalence of human papillomavirus in women screened for cervical cancer in Labrador, Canada Severini, Alberto Jiang, Ying Brassard, Paul Morrison, Howard Demers, Alain A. Oguntuase, Elizabeth Al-Rushdi, Muna Preston, Felicia Ratnam, Samuel Mao, Yang Int J Circumpolar Health Original Research Article BACKGROUND: A higher incidence of cervical cancer and human papillomavirus (HPV) infection has been reported in northern Canada and in First Nation, Métis and Inuit women, with some evidence to suggest that the HPV type distribution in these populations may be different from the rest of Canada. OBJECTIVE: The objective of this study was to measure the HPV type prevalence in Labrador women to determine if significant differences in HPV types could reduce the effectiveness of HPV vaccination. DESIGN: The prevalence of HPV types was determined in 1,370 women presenting for routine pap screening in Labrador between February and November 2010. Cervical cytology and HPV genotyping were performed on the same liquid-based cytology specimens. RESULTS: The overall prevalence of HPV was 21.4%; cytological abnormalities were found in 8.8% of the participants. HPV 16 and 18 were the most common high-risk HPV types. These two types were found in 52.4% of high-grade lesions. The prevalence in HPV infections was comparable across the Labrador regions. CONCLUSIONS: The present results support the potential effectiveness of the HPV immunization program in Labrador. Co-Action Publishing 2013-02-21 /pmc/articles/PMC3579953/ /pubmed/23440347 http://dx.doi.org/10.3402/ijch.v72i0.19743 Text en © 2013 Alberto Severini et al. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research Article
Severini, Alberto
Jiang, Ying
Brassard, Paul
Morrison, Howard
Demers, Alain A.
Oguntuase, Elizabeth
Al-Rushdi, Muna
Preston, Felicia
Ratnam, Samuel
Mao, Yang
Type-specific prevalence of human papillomavirus in women screened for cervical cancer in Labrador, Canada
title Type-specific prevalence of human papillomavirus in women screened for cervical cancer in Labrador, Canada
title_full Type-specific prevalence of human papillomavirus in women screened for cervical cancer in Labrador, Canada
title_fullStr Type-specific prevalence of human papillomavirus in women screened for cervical cancer in Labrador, Canada
title_full_unstemmed Type-specific prevalence of human papillomavirus in women screened for cervical cancer in Labrador, Canada
title_short Type-specific prevalence of human papillomavirus in women screened for cervical cancer in Labrador, Canada
title_sort type-specific prevalence of human papillomavirus in women screened for cervical cancer in labrador, canada
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579953/
https://www.ncbi.nlm.nih.gov/pubmed/23440347
http://dx.doi.org/10.3402/ijch.v72i0.19743
work_keys_str_mv AT severinialberto typespecificprevalenceofhumanpapillomavirusinwomenscreenedforcervicalcancerinlabradorcanada
AT jiangying typespecificprevalenceofhumanpapillomavirusinwomenscreenedforcervicalcancerinlabradorcanada
AT brassardpaul typespecificprevalenceofhumanpapillomavirusinwomenscreenedforcervicalcancerinlabradorcanada
AT morrisonhoward typespecificprevalenceofhumanpapillomavirusinwomenscreenedforcervicalcancerinlabradorcanada
AT demersalaina typespecificprevalenceofhumanpapillomavirusinwomenscreenedforcervicalcancerinlabradorcanada
AT oguntuaseelizabeth typespecificprevalenceofhumanpapillomavirusinwomenscreenedforcervicalcancerinlabradorcanada
AT alrushdimuna typespecificprevalenceofhumanpapillomavirusinwomenscreenedforcervicalcancerinlabradorcanada
AT prestonfelicia typespecificprevalenceofhumanpapillomavirusinwomenscreenedforcervicalcancerinlabradorcanada
AT ratnamsamuel typespecificprevalenceofhumanpapillomavirusinwomenscreenedforcervicalcancerinlabradorcanada
AT maoyang typespecificprevalenceofhumanpapillomavirusinwomenscreenedforcervicalcancerinlabradorcanada